Invention Grant
- Patent Title: Cycloalkyl substituted pyrimidinediamine compounds and their uses
- Patent Title (中): 环烷基取代的嘧啶二胺化合物及其用途
-
Application No.: US11567506Application Date: 2006-12-06
-
Publication No.: US07868013B2Publication Date: 2011-01-11
- Inventor: Hui Li , Ankush Argade , Rajinder Singh , Sambaiah Thota , David Carroll , Kin Tso , Vanessa Taylor , John McLaughlin , Mark Markovtsov
- Applicant: Hui Li , Ankush Argade , Rajinder Singh , Sambaiah Thota , David Carroll , Kin Tso , Vanessa Taylor , John McLaughlin , Mark Markovtsov
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Agent Travis Young
- Main IPC: C07D239/48
- IPC: C07D239/48 ; A61K31/506
Abstract:
The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.
Public/Granted literature
- US20070299060A1 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses Public/Granted day:2007-12-27
Information query
